Advertisement

Author: Patsy Newitt

Jordan Healthcare, a medical practice in Southwick, Mass., closed Jan. 21 following issues with insurance companies, MassLive reported Jan. 5. 

Pfizer, on behalf of its subsidiary Biohaven Pharmaceutical Holding Company, agreed to pay $59,746,277 to resolve allegations that prior to Pfizer's acquisition, Biohaven paid kickbacks to physicians to induce prescriptions of Biohaven’s drug Nurtec.

ASC leaders are optimistic about the future, citing opportunities for growth over the next five years, including the migration of cardiology procedures to ASCs and increasing patient interest.

Advertisement

From anesthesia reimbursement declines to supply chain costs, seven ASC leaders joined Becker's to discuss the biggest ASC challenges in 2025. 

From increased procedure complexity to surgical robots, six ASC leaders joined Becker's to discuss what they're most excited about in regards to ASC success in 2025. 

Becker's reported on four hospitals or health systems shuttering services since Jan. 1, which could shift how ASCs in these markets operate. 

Hospital deals surged in 2024 — the percentage of transactions with a financially distressed hospital hit an all time high and the average annual revenue of the distressed hospital inched up from $219 million in 2022 to $401 million last…

Advertisement